You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 571 ANV419 is a novel CD122-selective IL-2/anti-IL-2 antibody fusion protein with potent CD8 T cell and NK cell stimulatory function in vitro and in vivo

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
571 ANV419 is a novel CD122-selective IL-2/anti-IL-2 antibody fusion protein with potent CD8 T cell and NK cell stimulatory function in vitro and in vivo

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020142018
Dec 20202206
Jan 20213405
Feb 202134012
Mar 202164013
Apr 202192011
May 20212509
Jun 2021007
Jul 20210012
Aug 2021007
Sep 20210012
Oct 202168033
Nov 202162031
Dec 2021174021
Jan 202284018
Feb 202282017
Mar 2022182015
Apr 2022136013
May 202290010
Jun 202280016
Jul 202268012
Aug 202280013
Sep 2022100012
Oct 202286012
Nov 202284014
Dec 20224603
Jan 202388011
Feb 20236603
Mar 20236206
Apr 20235609
May 20234806
Jun 20235202
Jul 20234205
Aug 20235004
Sep 20232802
Oct 20238603
Nov 20236404
Dec 20234604
Jan 20242201
Feb 20242607
Mar 20244206
Apr 20241003
May 20243802
Jun 20244401
Jul 20243801
Aug 20243201
Sep 20242202
Oct 20248207
Nov 202456015
Dec 20244407
Jan 202546011
Feb 20251203
Mar 2025004
Apr 2025003
May 2025005
Jun 2025006
Total30370496